10-Q: Kun Peng Reports Q3 Loss Amid Revenue Decline

Kun Peng International Ltd. reported a reduced net loss for the nine months ended June 30, 2025, despite a significant revenue decrease, driven by one-time gains from subsidiary liquidations.

Summary

• For the nine months ended June 30, 2025, revenue decreased by 32.8% to $1,073,606, down from $1,598,728 in the prior year period.
• Net loss for the nine months ended June 30, 2025, was reduced to $888,749, compared to a net loss of $1,420,056 for the same period in 2024.
• Gross profit declined by 36.6% to $741,530, with the gross margin decreasing from 73.2% to 69.1%.
• Operating expenses decreased by $414,579 to $2,190,192, primarily due to reductions in general and administrative expenses and selling expenses.
• Cash and cash equivalents stood at $59,914 as of June 30, 2025, a decrease from $82,184 as of September 30, 2024.
• The company reported positive net cash provided by operating activities of $69,471 for the nine months ended June 30, 2025, a significant improvement from a net cash outflow of $206,462 in the prior year period.
• Working capital remained negative, worsening to $(8,384,987) as of June 30, 2025, from $(7,997,902) as of September 30, 2024.
• The company incurred short-term borrowing of $99,391 as of June 30, 2025, guaranteed by a shareholder.
• Amounts due to related parties increased to $4,190,668 as of June 30, 2025, from $4,069,413 as of September 30, 2024.

Sentiment

Score: 3

Explanation: While the net loss decreased and operating cash flow turned positive, these improvements are largely offset by a significant decline in core revenue, worsening negative working capital, and an explicit 'going concern' warning. The positive 'other income' is primarily from one-time events (subsidiary disposal/liquidation) rather than sustainable operational improvements, indicating severe financial distress and high operational risk.

Positives

• Net loss significantly reduced to $888,749 for the nine months ended June 30, 2025, from $1,420,056 in the prior year period.
• Shifted from negative to positive cash flow from operations, providing $69,471 for the nine months ended June 30, 2025.
• Equipment-based service revenue increased to $821,239 for the nine months ended June 30, 2025, up from $539,630.
• Recognized a $147,579 gain on the disposal of the King Eagle (Hangzhou) subsidiary.
• Recorded $517,865 in other income from the liquidation of assets and liabilities during the deregistration process for two subsidiaries, King Eagle (Huaian) and Kun Zhi Jian (Huaian).
• Management is actively focusing on increasing revenue through online platforms and trimming operating costs.
• Directors and stakeholders have expressed intent to continue providing financial assistance to support ongoing business operations.

Negatives

• Overall revenue decreased by 32.8% for the nine months ended June 30, 2025, primarily due to the termination of two subsidiaries' businesses and suspension of related business streams.
• Gross profit decreased by 36.6% and gross margin declined from 73.2% to 69.1%.
• Working capital worsened, increasing negative working capital from $7,997,902 to $8,384,987.
• Cash and cash equivalents decreased to $59,914 as of June 30, 2025.
• The company continues to face substantial doubt about its ability to continue as a going concern.
• Identified material weaknesses in internal control over financial reporting, including a lack of sufficient and adequately trained internal accounting and finance personnel, lack of segregation of duties, and absence of a functioning audit committee.
• Customer advances totaling $504,385 are non-refundable by management agreement but not legally bound, posing a potential refund risk.
• Amounts due to related parties increased to $4,190,668, which are interest-free, unsecured, and repayable on demand.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to persistent net losses and negative working capital.
• The company faces liquidity risk and may encounter difficulty raising sufficient funds to meet its commitments, relying heavily on loans from directors and major shareholders.
• Uncertainties exist regarding the interpretation and application of current and future PRC laws and regulations concerning the Variable Interest Entity (VIE) structure, which could necessitate restructuring.
• The enforceability and treatment of intercompany agreements within the organization, including intercompany borrowings and VIE contractual arrangements, have not been tested in court.
• Foreign currency exchange rate fluctuations between the RMB, HKD, and USD can materially and adversely affect liquidity and cash flows.
• A high concentration of vendors exists, with three major vendors accounting for 78.3% of the company's total cost of revenues for the nine months ended June 30, 2025.
• Customer advances, while deemed non-refundable by management, are not bound by written agreements, potentially allowing customers to demand refunds under commercial laws.
• Material weaknesses in internal control over financial reporting, including insufficient accounting personnel, lack of segregation of duties, and absence of a functioning audit committee, pose risks to financial reporting accuracy.
• Funds and assets located in the PRC and Hong Kong may not be available for use outside these regions due to potential interventions or restrictions imposed by the PRC government.
• PRC tax authorities generally have up to five years to assess underpaid tax, and indefinitely in cases of tax evasion, posing a risk of future tax liabilities.
• There is no assurance that the company will be able to increase revenue, successfully implement its business plan, or obtain financing on commercially acceptable terms, if at all, and future share issuances would dilute existing stockholders.

Future Outlook

The company plans to continue exploring additional revenue streams, leveraging healthcare expertise and technology with local service providers, promoting and selling preventive health care dietary supplements, and offering equipment-based services at the Kun Zhi Jian Customer Service Center. Chengdu Wenjiang Pengrun Internet Healthcare Co., Ltd. is expected to commence operations in late 2025, contingent on obtaining necessary permits. The majority of deferred revenue is anticipated to be recognized in fiscal year 2026.

Management Comments

• "We believe preventive care is the most effective investment in health."
• "The Company continues to monitor its operations to help improve its financial liquidity."
• "The Company has been focusing on increasing its revenue through its online platform and trimming its operating costs."
• "Our directors have indicated that they intend to continue to support the group by providing adequate financial assistance to enable the group to continue its business operations for the foreseeable future."
• "We are currently hiring additional personnel in financial reporting and accounting, and we are providing training to newly hired personnel. In addition, once our cash position improves, we plan to hire an experienced controller and work to build an internal accounting team with sufficient in-house expertise in U.S. GAAP reporting."

Industry Context

The company operates in the preventive health care and health-related household products market in the PRC, leveraging online platforms. This sector has seen increased consumer consciousness due to global health issues like the COVID-19 pandemic. The company's business model, which includes online sales, health screening, and consulting services, aligns with the growing trend of digital health and preventive care in China. However, the industry is subject to PRC regulations on foreign investment and online healthcare services, which can introduce operational uncertainties.

Comparison to Industry Standards

• The company's persistent negative working capital of over $8 million and explicit 'going concern' warning indicate a financial position significantly below typical industry profitability and liquidity standards for established companies.
• While the shift to positive operating cash flow is a positive sign, the substantial decline in overall revenue (32.8%) and gross profit (36.6%) suggests challenges in core business performance compared to growth-oriented industry peers.
• The reliance on related party funding for operational support and the identified material weaknesses in internal controls are significant deviations from best practices in corporate governance and financial management observed in more mature or well-capitalized industry players.

Corporate Governance

Legal Proceedings

• The company is currently not involved in any litigation that it believes could have a material adverse effect on its financial condition or results of operations.

Related Party Transactions

• Acquisition of Kun Pin Hui (Shandong) Trading Co. Ltd. from Zhandong Fan and Yuanyuan Zhang (shareholders of King Eagle (Tianjin)) for a nominal consideration of $0.28.
• Amounts due from related parties totaled $83,757 as of June 30, 2025, primarily advances to King Eagle (Hangzhou) Health Technology Co., Ltd. for operating expenses.
• Amounts due to related parties totaled $4,190,668 as of June 30, 2025, representing operational support and agency service charges from various individuals and entities related to King Eagle (Tianjin) shareholders and management. These payables are interest-free, unsecured, and repayable on demand.

Stakeholder Impact

• Shareholders face potential dilution from future share issuances and significant risk of loss due to ongoing going concern issues and negative financial performance.
• Employees may be impacted by subsidiary deregistration and ongoing cost-trimming efforts.
• Customers who made advance payments face a risk of non-refundability if the company encounters severe liquidity issues, as the non-refundable term is not legally binding.
• Related party creditors bear significant exposure due to over $4.19 million in unsecured, on-demand payables.
• Suppliers, particularly the three major vendors accounting for 78.3% of cost of revenues, are highly reliant on the company's financial health and could be impacted by further deterioration.

Next Steps

• Continue to explore additional revenue streams.
• Leverage health care expertise and technology with local health care service providers.
• Promote and sell preventive health care dietary supplements and products.
• Offer health care equipment-based services at the Kun Zhi Jian Customer Service Center.
• Chengdu Wenjiang Pengrun Internet Healthcare Co., Ltd. plans to commence operations in late 2025, assuming necessary permits are obtained.
• Anticipate recognition of the majority of deferred revenue in fiscal year 2026.
• Hire additional personnel in financial reporting and accounting.
• Provide training to newly hired personnel.
• Plan to hire an experienced controller and build an internal accounting team once the cash position improves.

Key Dates

Recommendation

The company faces severe financial challenges, including a substantial going concern doubt, persistent negative working capital, and a significant decline in core revenue streams. While net loss decreased, this was largely due to one-time gains from subsidiary disposals/liquidations rather than improved operational profitability. The identified material weaknesses in internal controls and heavy reliance on related-party funding further exacerbate the risk profile. The overall financial health indicates a high probability of continued decline and potential failure, making it a high-risk investment with a strong sell recommendation.

Keywords

Kun Peng International, KPEA, Health Care Products, E-commerce, China, SEC Filing, 10-Q, Financial Results, Going Concern, VIE Structure, Online Platform, King Eagle Mall, Kun Zhi Jian, Preventive Health Care, Financial Reporting, Risk Management